Higher gametocyte prevalence following failure of treatment of Plasmodium falciparum malaria with sulfadoxine-pyrimethamine and the combination of chloroquine plus sulfadoxine-pyrimethamine: Implications for progression of anti-folate resistance

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 96, Issue 4, 2002, Pages 434-437

  Tjitra, Emiliana ^a,c   Suprianto, Sri ^b   Anstey, Nicholas M ^c  

^a NATIONAL INSTITUTE OF HEALTH RESEARCH AND DEVELOPMENT   (Indonesia)

^b Directorate of Non Communicable Disease Control   (Indonesia)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

Chemotherapy; Combination treatment; Gametocytaemia; Indonesia; Malaria; Plasmodium falciparum; Sulfadoxine pyrimethamine

Indexed keywords

ANTIMALARIAL AGENT; ARTESUNATE; CHLOROQUINE; FANSIDAR; FOLIC ACID ANTAGONIST; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ARTICLE; CHILD; CLINICAL PROTOCOL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GAMETOCYTE; GENETIC STRAIN; HUMAN; IN VIVO STUDY; INDONESIA; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MONOTHERAPY; PARASITE PREVALENCE; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; TREATMENT FAILURE; WORLD HEALTH ORGANIZATION; ADOLESCENT; ADULT; AGED; ANIMAL; DISEASE COURSE; DRUG COMBINATION; GROWTH, DEVELOPMENT AND AGING; MIDDLE AGED; PRESCHOOL CHILD; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM; PROTOZOA;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; CHLOROQUINE; DISEASE PROGRESSION; DRUG COMBINATIONS; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SULFADOXINE; TREATMENT OUTCOME;

EID: 0036654973     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(02)90385-8     Document Type: Article

References (22)

1. Bishop, A. (1954). The effect of sulphadiazine, proguanil and 2:4-diamino-6:7-diisopropylpteridine upon gametocyte production in Plasmodium gallinaceum (Brumpt, 1935). Parasitology, 44, 120-131.
2. Bishop, A. (1955). Problems concerning gametogenesis in Haemosporidea, with particular reference to the genus Plasmodium. Parasitology, 45, 163-185.
3. Bray, R., Burgess, R., Rox, R. & Miller, M. (1959). Effect of pyrimethamine upon sporogony and erythrocytic schizogony of Laverinia falciparum. Bulletin of the World Health Organization, 21, 233-238.
4. Buckling, A., Ranford-Cartwright, L. C., Miles, A. & Read, A. F. (1999). Chloroquine increases Plasmodium falciparum gametocytogenesis in vitro. Parasitology, 118, 339-346.
5. Butcher, G. (1997). Antimalarial drugs and the mosquito transmission of malaria. International Journal for Parasitology, 27, 975-987.
6. Dean, A. G., Dean, J., Coulombier, D., Brendel, K. A., Smith, D. C., Burton, A. H., Dicker, R. C., Sullivan, K., Fagan, R. F. & Arner, T. G. (1995). Epi Info, Version 6: a word-processing database, and statistics program for public health on IBM-compatible microcomputers. Atlanta: Centers for Disease Control and Prevention.
7. Eichner, M., Diebner, H. H., Molineaux, L., Collins, W. E., Jeffery, G. M. & Dietz, K. (2001). Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data. Transactions of the Royal Society of Tropical Medicine and Hygiene, 95, 497-501.
8. Handunnetti, S. M., Gunawardena, D. M., Pathirana, P. P. S. L., Ekanayake, K., Weerasinghe, S. & Mendis, K. N. (1996). Features of recrudescent chloroquine-resistant Plasmodium falciparum infections confer a survival advantage on parasites and have implications for disease control. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 563-567.
9. Hogh, B., Gamage-Mendis, A., Butcher, G. A., Thompson, R., Begtrup, K., Mendis, C., Enosse, S. M., Dgedge, M., Barreto, J., Eling, W. & Sinden, R. E. (1998). The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector. American Journal of Tropical Medicine and Hygiene, 58, 176-182.
10. McIntosh, H. M. & Greenwood, B. M. (1998). Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria - a systematic review. Annals of Tropical Medicine and Parasitology, 92, 265-270.
11. Nosten, F., van Vugt, M., Price, R., Luxemburger, C., Thway, K. L., Brockman, A., McGready, R., ter Kuile, F., Looareesuwan, S. & White, N. J. (2000). Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet, 356, 297-302.
12. Robert, V., Molez, J.-F. & Trape, J.-F. (1996). Gametocytes, chloroquine pressure, and the relative parasite survival advantage of resistant strains of falciparum malaria in West Africa. American Journal of Tropical Medicine and Hygiene, 55, 350-351.
13. Robert, V., Awono-Ambene, H. P., Le Hesran, J.-Y. & Trape, J.-F. (2000). Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine. American Journal of Tropical Medicine and Hygiene, 62, 210-216.
14. Shinondo, C. J., Lanners, H. N., Lowrie, R. C. Jr & Wiser, M. F. (1994). Effect of pyrimethamine resistance on sporogony in a Plasmodium berghei/Anopheles stephensi model. Experimental Parasitology, 78, 194-202.
15. Sokhna, C. S., Trape, J.-F. & Robert, V. (2001). Gametocytaemia in Senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine. Parasite, 8, 243-250.
16. Targett, G., Drakeley, C., Jawara, M., von Seidlein, L., Coleman, R., Deen, J., Pinder, M., Doherty, T., Sutherland, C., Walraven, G. & Milligan, P. (2001). Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. Journal of Infectious Diseases, 183, 1254-1259.
17. Temu, P. I. (2000). New Treatment Protocol for Malaria in Papua New Guinea. Port Moresby, Department of Health of Papua New Guinea, pp. 1-4.
18. Tjitra, E., Suprianto, S., Dyer, M., Currie, B. J. & Anstey, N. M. (1999). Evaluation of the therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine in uncomplicated falciparum malaria in eastern Indonesia: high rates of chloroquine treatment failure with poor hematological recovery [Abstract]. American Journal of Tropical Medicine and Hygiene, 61, supplement, 286-287.
19. Tjitra, E., Suprianto, S., Currie, B. J., Morris, P. S., Saunders, J. R. & Anstey, N. M. (2001). Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia. American Journal of Tropical Medicine and Hygiene, 65, 309-317.
20. Von Seidlein, L., Milligan, P., Pinder, M., Bojang, K., Anyalebechi, C., Gosling, R., Coleman, R., Ude, J. I., Sadiq, A., Duraisingh, M., Warhurst, D., Alloueche, A., Targett, G., McAdam, K., Greenwood, B., Walraven, G., Olliaro, P. & Doherty, T. (2000). Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet, 355, 352-357.
21. White, N. J., Nosten, F., Looareesuwan, S., Watkins, W. M., Marsh, K., Snow, R. W., Kokwaro, G., Ouma, J., Hien, T. T., Molyneux, M. E., Taylor, T. E., Newbold, C. I., Ruebush, T. K. II, Danis, M., Greenwood, B. M., Anderson, R. M. & Olliaro, P. (1999). Averting a malaria disaster. Lancet, 353, 1965-1967.
22. WHO (1997). Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria. Draft 28.2.97. Geneva: Division of Control of Tropical Diseases, World Health Organization, pp. 1-33.